Efficacy and Safety Study of Satralizumab (SA237) as Monotherapy to Treat Participants With Neuromyelitis Optica (NMO) and Neuromyelitis Optica Spectrum Disorder (NMOSD)
Public ClinicalTrials.gov record NCT02073279. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Satralizumab (SA237) as Monotherapy in Patients With Neuromyelitis Optica (NMO) and Neuromyelitis Optica Spectrum Disorder (NMOSD)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The objectives of this study are to evaluate the efficacy, safety, pharmacodynamic, pharmacokinetic and immunogenic profiles of satralizumab in participants with NMO and NMOSD.
Study identification
- NCT ID
- NCT02073279
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 95 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years to 74 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 5, 2014 (Actual)
- Primary completion
- Oct 12, 2018 (Actual)
- Completion
- Jan 31, 2022 (Actual)
- Last update posted
- Mar 1, 2023
2014 – 2022
United States locations
- U.S. sites
- 20
- U.S. states
- 12
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Colorado Denver -; Neurology | Aurora | Colorado | 80045 | — |
| University of Miami UHealth Professional Arts Center | Miami | Florida | 33136 | — |
| The MS Center of Vero Beach | Vero Beach | Florida | 32962 | — |
| Columbus Research and Wellness | Columbus | Georgia | 31909 | — |
| University of Chicago; Neurology | Chicago | Illinois | 60637 | — |
| Consultants in Neurology Ltd | Northbrook | Illinois | 60062 | — |
| OSF Saint Francis Medical Center | Peoria | Illinois | 64637 | — |
| University of Kansas Medical Center | Kansas City | Kansas | 66160 | — |
| MidAmerica Neuroscience Institute | Prairie Village | Kansas | 66206 | — |
| University of Michigan Health System | Ann Arbor | Michigan | 48109-0666 | — |
| Wayne State University - Comp Clinic and MS. Center | Detroit | Michigan | 48201 | — |
| University of North Carolina at Chapel Hill | Chapel Hill | North Carolina | 27599 | — |
| The Neurological Institute PA | Charlotte | North Carolina | 28204 | — |
| OhioHealth Research Institute | Columbus | Ohio | 43214 | — |
| Thomas Jefferson University | Philadelphia | Pennsylvania | 19107 | — |
| University of Texas Southwestern Medical Center | Dallas | Texas | 75390 | — |
| Central Texas Neurology Consultants | Round Rock | Texas | 78681 | — |
| UT Medicine San Antonio | San Antonio | Texas | 78229 | — |
| Virginia Commonwealth University | Richmond | Virginia | 23219-1901 | — |
| Wheaton Franciscan Healthcare - St. Francis Outpatient Center; Center for Neurological Disorders | Milwaukee | Wisconsin | 53215 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 38 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02073279, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 1, 2023 · Synced Oct 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02073279 live on ClinicalTrials.gov.